Skip to main content
. 2009 Oct 6;9:354. doi: 10.1186/1471-2407-9-354

Table 5.

Proportion of promoter hypermethylation in MGMT, CDKN2A and RASFF1 in oral and pharyngeal cancer tissues

N of subjects (%)
N = 61
MGMT CDKN2A RASSF1
35 (57.3) - - -
13 (21.3) + - -
5 (8.2) - + -
2 (3.3) - - +
4 (6.6) + - +
1 (1.6) + + -
0 (0.0) - + +
1 (1.6) + + +

+: methylated

-: unmethylated

HHS Vulnerability Disclosure